171 related articles for article (PubMed ID: 36576549)
21. Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer.
Delli Pizzi A; Caposiena D; Mastrodicasa D; Trebeschi S; Lambregts D; Rosa C; Cianci R; Seccia B; Sessa B; Di Flamminio FM; Chiacchiaretta P; Caravatta L; Cinalli S; Di Sebastiano P; Caulo M; Genovesi D; Beets-Tan R; Basilico R
Abdom Radiol (NY); 2019 Nov; 44(11):3595-3605. PubMed ID: 31444557
[TBL] [Abstract][Full Text] [Related]
22. Early conformational changes at tumour bed and long term response after neoadjuvant therapy in locally-advanced rectal cancer.
Santiago I; Barata MJ; Figueiredo N; Parés O; Matos C
Eur J Radiol; 2021 Jul; 140():109742. PubMed ID: 33971571
[TBL] [Abstract][Full Text] [Related]
23. Reduced and standard field-of-view diffusion weighted imaging in patients with rectal cancer at 3 T-Comparison of image quality and apparent diffusion coefficient measurements.
Attenberger UI; Tavakoli A; Stocker D; Stieb S; Riesterer O; Turina M; Schoenberg SO; Pilz L; Reiner CS
Eur J Radiol; 2020 Oct; 131():109257. PubMed ID: 32947092
[TBL] [Abstract][Full Text] [Related]
24. MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study.
Yuval JB; Patil S; Gangai N; Omer DM; Akselrod DG; Fung A; Harmath CB; Kampalath R; Krehbiel K; Lee S; Liu PS; Millet JD; O'Malley RB; Purysko AS; Veniero JC; Wasnik AP; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2023 Aug; 33(8):5761-5768. PubMed ID: 36814032
[TBL] [Abstract][Full Text] [Related]
25. Magnetic Resonance of Rectal Cancer Response to Therapy: An Image Quality Comparison between 3.0 and 1.5 Tesla.
Caruso D; Zerunian M; De Santis D; Biondi T; Paolantonio P; Rengo M; Bellini D; Ferrari R; Ciolina M; Lucertini E; Polici M; Iannicelli E; Tombolini V; Laghi A
Biomed Res Int; 2020; 2020():9842732. PubMed ID: 33102603
[TBL] [Abstract][Full Text] [Related]
26. MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy.
Jang JK; Choi SH; Park SH; Kim KW; Kim HJ; Lee JS; Kim AY
Eur Radiol; 2020 Apr; 30(4):2312-2323. PubMed ID: 31953656
[TBL] [Abstract][Full Text] [Related]
27. Role of MRI and added value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of local recurrence from rectal cancer.
Molinelli V; Angeretti MG; Duka E; Tarallo N; Bracchi E; Novario R; Fugazzola C
Abdom Radiol (NY); 2018 Nov; 43(11):2903-2912. PubMed ID: 29541831
[TBL] [Abstract][Full Text] [Related]
28. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?
Sassen S; de Booij M; Sosef M; Berendsen R; Lammering G; Clarijs R; Bakker M; Beets-Tan R; Warmerdam F; Vliegen R
Eur Radiol; 2013 Dec; 23(12):3440-9. PubMed ID: 23832319
[TBL] [Abstract][Full Text] [Related]
29. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Sathyakumar K; Chandramohan A; Masih D; Jesudasan MR; Pulimood A; Eapen A
Br J Radiol; 2016; 89(1060):20150328. PubMed ID: 26828967
[TBL] [Abstract][Full Text] [Related]
30. Magnetic Resonance Assessment of Peritoneal Carcinomatosis: Is There a True Benefit From Diffusion-Weighted Imaging?
Cianci R; Delli Pizzi A; Patriarca G; Massari R; Basilico R; Gabrielli D; Filippone A
Curr Probl Diagn Radiol; 2020; 49(6):392-397. PubMed ID: 31248709
[TBL] [Abstract][Full Text] [Related]
31. Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.
Cho MS; Kim H; Han YD; Hur H; Min BS; Baik SH; Cheon JH; Lim JS; Lee KY; Kim NK
Medicine (Baltimore); 2019 Aug; 98(35):e16614. PubMed ID: 31464897
[TBL] [Abstract][Full Text] [Related]
32. T staging of rectal cancer: accuracy of diffusion-weighted imaging compared with T2-weighted imaging on 3.0 tesla MRI.
Feng Q; Yan YQ; Zhu J; Xu JR
J Dig Dis; 2014 Apr; 15(4):188-94. PubMed ID: 24373561
[TBL] [Abstract][Full Text] [Related]
33. Primary and post-chemoradiotherapy MRI detection of extramural venous invasion in rectal cancer: the role of diffusion-weighted imaging.
Fornell-Perez R; Vivas-Escalona V; Aranda-Sanchez J; Gonzalez-Dominguez MC; Rubio-Garcia J; Aleman-Flores P; Lozano-Rodriguez A; Porcel-de-Peralta G; Loro-Ferrer JF
Radiol Med; 2020 Jun; 125(6):522-530. PubMed ID: 32020526
[TBL] [Abstract][Full Text] [Related]
34. Endoscopy and MRI for restaging early rectal cancer after neoadjuvant treatment.
Stijns RCH; Leijtens J; de Graaf E; Bach SP; Beets G; Bremers AJA; Beets-Tan RGH; de Wilt JHW
Colorectal Dis; 2023 Feb; 25(2):211-221. PubMed ID: 36104011
[TBL] [Abstract][Full Text] [Related]
35. How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
Jang JK; Lee CM; Park SH; Kim JH; Kim J; Lim SB; Yu CS; Kim JC
Korean J Radiol; 2021 Sep; 22(9):1451-1461. PubMed ID: 34132075
[TBL] [Abstract][Full Text] [Related]
36. Value of gadofosveset-enhanced MRI and multiplanar reformatting for selecting good responders after chemoradiation for rectal cancer.
Heijnen LA; Maas M; Lahaye MJ; Lalji U; Lambregts DM; Martens MH; Riedl RG; Beets GL; Beets-Tan RG
Eur Radiol; 2014 Aug; 24(8):1845-52. PubMed ID: 24898096
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
[TBL] [Abstract][Full Text] [Related]
38. Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.
Prezzi D; Muthuswamy K; Amlani A; Owczarczyk K; Elowaidy A; Mistry T; Bassett P; Goh V
Eur Radiol; 2023 Nov; 33(11):7575-7584. PubMed ID: 37462820
[TBL] [Abstract][Full Text] [Related]
39. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
[TBL] [Abstract][Full Text] [Related]
40. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
